Approval Year
| Substance Class |
Structurally Diverse
Created
by
admin
on
Edited
Sat Dec 16 13:18:57 GMT 2023
by
admin
on
Sat Dec 16 13:18:57 GMT 2023
|
| Source Materials Class | ORGANISM |
| Source Materials Type | MAMMAL |
| Source Materials Parent | |
| Part | PLASMA |
| Fraction Material Type | PROTEIN |
| Fraction Name | IGG |
| Record UNII |
YB12NQZ1YN
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Related Record | Type |
|---|
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NDF-RT |
N0000184163
Created by
admin on Sat Dec 16 13:18:58 GMT 2023 , Edited by admin on Sat Dec 16 13:18:58 GMT 2023
|
||
|
FDA ORPHAN DRUG |
343911
Created by
admin on Sat Dec 16 13:18:58 GMT 2023 , Edited by admin on Sat Dec 16 13:18:58 GMT 2023
|
||
|
FDA ORPHAN DRUG |
2584
Created by
admin on Sat Dec 16 13:18:58 GMT 2023 , Edited by admin on Sat Dec 16 13:18:58 GMT 2023
|
||
|
NCI_THESAURUS |
C307
Created by
admin on Sat Dec 16 13:18:58 GMT 2023 , Edited by admin on Sat Dec 16 13:18:58 GMT 2023
|
||
|
WHO-ATC |
V03AB24
Created by
admin on Sat Dec 16 13:18:58 GMT 2023 , Edited by admin on Sat Dec 16 13:18:58 GMT 2023
|
||
|
WHO-ATC |
J07AN01
Created by
admin on Sat Dec 16 13:18:58 GMT 2023 , Edited by admin on Sat Dec 16 13:18:58 GMT 2023
|
||
|
FDA ORPHAN DRUG |
5685
Created by
admin on Sat Dec 16 13:18:58 GMT 2023 , Edited by admin on Sat Dec 16 13:18:58 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
YB12NQZ1YN
Created by
admin on Sat Dec 16 13:18:58 GMT 2023 , Edited by admin on Sat Dec 16 13:18:58 GMT 2023
|
PRIMARY | |||
|
N0000184150
Created by
admin on Sat Dec 16 13:18:58 GMT 2023 , Edited by admin on Sat Dec 16 13:18:58 GMT 2023
|
PRIMARY | Digoxin Binding Activity [MoA] | ||
|
1745257
Created by
admin on Sat Dec 16 13:18:58 GMT 2023 , Edited by admin on Sat Dec 16 13:18:58 GMT 2023
|
PRIMARY | |||
|
YB12NQZ1YN
Created by
admin on Sat Dec 16 13:18:58 GMT 2023 , Edited by admin on Sat Dec 16 13:18:58 GMT 2023
|
PRIMARY | |||
|
N0000007920
Created by
admin on Sat Dec 16 13:18:58 GMT 2023 , Edited by admin on Sat Dec 16 13:18:58 GMT 2023
|
PRIMARY | Immunoglobulins [Chemical/Ingredient] | ||
|
Digoxin Immune Fab
Created by
admin on Sat Dec 16 13:18:58 GMT 2023 , Edited by admin on Sat Dec 16 13:18:58 GMT 2023
|
PRIMARY | |||
|
C80835
Created by
admin on Sat Dec 16 13:18:58 GMT 2023 , Edited by admin on Sat Dec 16 13:18:58 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SUB_CONCEPT->SUBSTANCE |
|
||
|
TARGET -> INHIBITOR |
|
||
|
|
SUB_CONCEPT->SUBSTANCE |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
|
Agent Modifications
| Modification Process | Modification Role | Modification Type | Amount | Fragment Name | Fragment ID |
|---|---|---|---|---|---|
| IMMUNIZATION | TARGETED ANTIGEN | IMMUNOLOGICAL |
|
Digoxin | 73K4184T59 |
| FAB GENERATION | HYDROLYSIS | Papain | A236A06Y32 |